Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Carlsbad, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lineage Cell Therapeutics, Inc. has filed 1,802 SEC EDGAR filings since 17 Apr 1996

SEC filing history

Showing 401-425 of 1,000 matching filings.

Per page
25
Current page
17
SC 13D/A

SC 13D/A filing

Filing date
08 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-12830

10-Q filing

Filing date
08 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
425 File 001-12830

425 filing

Filing date
08 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12830

8-K filing

Filing date
08 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12830

8-K filing

Filing date
08 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-12830

425 filing

Filing date
08 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Oct 2018
Reporting date
04 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Oct 2018
Reporting date
04 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12830

8-K filing

Filing date
05 Oct 2018
Reporting date
04 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-12830

25-NSE filing

Filing date
27 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Sep 2018
Reporting date
17 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Sep 2018
Reporting date
17 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
19 Sep 2018
Reporting date
17 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12830

8-K filing

Filing date
18 Sep 2018
Reporting date
17 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2018
Reporting date
11 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12830

8-K filing

Filing date
31 Aug 2018
Reporting date
30 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A filing

Filing date
22 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12830

BIOTIME, INC. 8-K

Filing date
02 Aug 2018
Reporting date
02 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-12830

10-Q filing

Filing date
02 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
8-K File 001-12830

8-K filing

Filing date
02 Aug 2018
Reporting date
01 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jul 2018
Reporting date
10 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jul 2018
Reporting date
10 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jul 2018
Reporting date
01 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jul 2018
Reporting date
01 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jul 2018
Reporting date
01 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .